This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
Written by
moderna inc.
CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event:
Barclays Speaking the Science Call Series, on Monday, June 16th at 10:00am ET
A live webcast of this presentation will be available under “Events and Presentations” in the Investors section of the Moderna website.
A replay of this webcast will be archived on Moderna’s website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations 617-209-5834 Lavina.Talukdar@modernatx.com
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media
BROOKLYN, NY / ACCESS Newswire / June 12, 2025 / IEH Corporation (OTC PINK:IEHC) today filed with the Securities and Exchange Commission (SEC) its Annual…
The campaign will air nationally on CNBC, FOX Business, Bloomberg, and inside NTTS’s weekly investor-focused television broadcasts-along with distribution across New to The Street’s 2.6M…
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / On June 11, 2025, Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq:ADUR)(CSE:ACT)(FSE:9D5),…
NEWPORT BEACH, CA / ACCESS Newswire / June 12, 2025 / Amaze Holdings, Inc. (NYSE American:AMZE) (“Amaze” or the “Company”),a global leader in creator-powered commerce,…
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / SMX (Security Matters) Public Limited Company (NASDAQ:SMX; SMXWW) (the “Company”), today announced that…
LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / June 12, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) and Mkango Resources Ltd. (AIM:MKA)(TSXV:MKA) (“Mkango”) are…
Highlights: Portal construction commenced with initial blast completed Underground operations expected to contribute to production in June and ramp up during Q3 2025 Open pit…
NORTH BILLERICA, MA / ACCESS Newswire / June 11, 2025 / Tecogen Inc. (NYSE American:TGEN) a leading manufacturer of clean energy products, today announced that…
Distinguished Diplomat Joins Former Labor Secretary Alex Acosta on Public Company Board BOCA RATON, FL / ACCESS Newswire / June 11, 2025 / Newsmax Inc….
ISTANBUL, TR / ACCESS Newswire / June 11, 2025 / Hair transplants have become more visible, more available, and more consistent. Social media is filled…
Filming Begins Thursday, June 12 at the New York Stock Exchange – Campaign Includes National TV Coverage, Earned Media, TV Commercials, and Full Social Media…
LAS VEGAS, NV / ACCESS Newswire / June 11, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions for institutions and…
Two parallel goals for Canalevia-CA1 (crofelemer delayed-release tablets): To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the…
New AI-powered platform turns conversations into insights for quality assurance, performance gains, and coaching opportunities – amplifying human decision-making without replacing it. GAINESVILLE, FL /…
Clear Start Tax Warns That Hitting $10,000 in IRS Debt Can Trigger Serious Consequences – Including Passport Restrictions and Federal Liens IRVINE, CA / ACCESS…
Collaboration to Integrate NRC-Approved Instrumentation and Control (I&C), Safety Systems, and Manufacturing Support as Reactor Development Advances Toward 2028 Deployment NEW YORK, NY AND DALLAS,…
CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event: Barclays Speaking…
Team of global leaders to showcase telcos’ advancing role in enabling immersive, context-aware digital experiences FOSTER CITY, CA / ACCESS Newswire / June 11, 2025…
C-level executive at Afinia provides extensive context on AstroNova’s quality issues, go-to-market failures, and MTEX technology’s reliability challenges and risks Askeladden Capital believes AstroNova’s Board…
LAS VEGAS, NEVADA / ACCESS Newswire / June 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech,…
